Bharat Biotech to set up Covaxin plant in Gujarat
Hyderabad: Bharat Biotech announced that it is going to set up an additional manufacturing unit of Covaxin in Gujarat to increase the production of the vaccine. As the nation facing a severe shortage of vaccines, Chiron Behring a subsidy of Bharat Biotech in Ankleshwar, Gujarat pans to produce 200 million doses of Covaxin per annum. "GMP facilities are already in the production of vaccines based on Inactivated Vero Cell Platform Technology" as per the company statement.
The company stated that the availability of the product at Ankleshwar to start from Q4 2021. Bharat Biotech had already manufacturing Covaxin at its Hyderabad and Bengaluru campuses.